Market Research Logo

Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review

Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate (ADC) indicated for the treatment of relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (sALCL). Seattle Genetics' product pipeline consists of ASG-22ME (enfortumab vedotin) for metastatic urothelial cancer. Its pipeline also comprises various antibody-drug conjugate (ADC) programs and immuno-oncology programs in various clinical stages of development. It uses ADC and sugar-engineered antibody (SEA) technologies for the development of its product portfolio. The company sells its products through pharmaceutical distributors and collaborators. Seattle Genetics is headquartered in Bothell, Washington, the US.

Seattle Genetics Inc Key Recent Developments

Feb 06,2018: Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results
Jan 08,2018: Seattle Genetics Highlights Leadership in Expanding Field of Antibody-Drug Conjugates (ADCs) at the 36th Annual J.P. Morgan Healthcare Conference
Dec 04,2017: Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics
Oct 26,2017: Seattle Genetics Reports Third Quarter 2017 Financial Results
Jul 27,2017: Seattle Genetics Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Seattle Genetics Inc - Key Facts
Seattle Genetics Inc - Key Employees
Seattle Genetics Inc - Key Employee Biographies
Seattle Genetics Inc - Major Products and Services
Seattle Genetics Inc - History
Seattle Genetics Inc - Company Statement
Seattle Genetics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Seattle Genetics Inc - Business Description
Seattle Genetics Inc - Corporate Strategy
Seattle Genetics Inc - SWOT Analysis
SWOT Analysis - Overview
Seattle Genetics Inc - Strengths
Seattle Genetics Inc - Weaknesses
Seattle Genetics Inc - Opportunities
Seattle Genetics Inc - Threats
Seattle Genetics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Seattle Genetics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 06, 2018: Seattle Genetics Reports Fourth Quarter and Year 2017 Financial Results
Jan 08, 2018: Seattle Genetics Highlights Leadership in Expanding Field of Antibody-Drug Conjugates (ADCs) at the 36th Annual J.P. Morgan Healthcare Conference
Dec 04, 2017: Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics
Oct 26, 2017: Seattle Genetics Reports Third Quarter 2017 Financial Results
Jul 27, 2017: Seattle Genetics Reports Second Quarter 2017 Financial Results
Apr 27, 2017: Seattle Genetics Reports First Quarter 2017 Financial Results
Apr 03, 2017: Seattle Genetics Presents Data Advancing Antibody-Drug Conjugate and Novel Immuno-Oncology Programs at the American Association for Cancer Research Annual Meeting
Mar 30, 2017: Seattle Genetics Highlights Leadership in Antibody-Drug Conjugate Technology Innovation at the American Association for Cancer Research (AACR) Annual Meeting
Mar 30, 2017: Seattle Genetics Highlights Leadership in Antibody-Drug Conjugate Technology Innovation at the American Association for Cancer Research (AACR) Annual Meeting
Feb 09, 2017: Seattle Genetics Reports Fourth Quarter and Year 2016 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Seattle Genetics Inc, Key Facts
Seattle Genetics Inc, Key Employees
Seattle Genetics Inc, Key Employee Biographies
Seattle Genetics Inc, Major Products and Services
Seattle Genetics Inc, History
Seattle Genetics Inc, Subsidiaries
Seattle Genetics Inc, Key Competitors
Seattle Genetics Inc, Ratios based on current share price
Seattle Genetics Inc, Annual Ratios
Seattle Genetics Inc, Annual Ratios (Cont...1)
Seattle Genetics Inc, Interim Ratios
Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Seattle Genetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Seattle Genetics Inc, Performance Chart (2013 - 2017)
Seattle Genetics Inc, Ratio Charts
Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Seattle Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report